A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...

A breakthrough discovery in enzyme science could revolutionize the treatment of autoimmune disorders and other diseases tied ...

The Food and Drug Administration (FDA) has approved 2 additional vial sizes of Niktimvo ™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” would ...

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” would ...

The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about initial phase II data from Xilio ...

Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of multiple malignant tumors. To date, toripalimab has been approved for marketing ...

New Activin R-based medications can emerge as perfect solutions for balancing weight loss and muscle building, making a ...

A recent study has identified a previously unknown antibody target on the Plasmodium falciparum sporozoite surface, providing ...

Learn more› By Kaitlyn Wells and Zoe Vanderweide If you believe the hype, blue-light blocking glasses will prevent headaches, decrease eyestrain, and help you sleep like a baby. But do they work?

But once inside, investigators said the Presidential Security Service (PSS) used minibuses and cars to block the driveway, then hundreds of PSS officers linked hands and formed a human chain to ...